Watch out: major regulatory shift potentially incoming. The U.S. administration is signaling moves to ease federal restrictions on marijuana—a policy that could reshape how we think about Schedule I substances. The substance is reportedly set to be reclassified from Schedule I (same tier as LSD and heroin) down to Schedule III (comparable to Tylenol with codeine or certain steroids). This kind of federal loosening could happen via executive order within days. While it's not directly crypto, these policy pivots often signal broader deregulation trends worth monitoring. When one federal appetite for strict substance control loosens, it sometimes creates ripple effects across other industries too.